Automation index

How much of a Social integrator’s job can AI already do?

A stock pathway comes earlier. Sitting with someone who fits nowhere until they take a step do not.

This percentage does not predict how many people will lose their jobs.

Task comparison

IS WORK OVER?

22%

AI can already do 22% of this job.

#344 / 633

Social integrator

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
Pathways, reports and case coordination. Estimate No public source provides a precise figure. This is our estimate.	16%	40%	+6.4
Go along in the street, the flat and the missed appointment. Estimate No public source provides a precise figure. This is our estimate.	18%	12%	+2.2
Network, resources and fighting for a place. Estimate No public source provides a precise figure. This is our estimate.	16%	28%	+4.5
Group, conflict and the one who walks out. Estimate No public source provides a precise figure. This is our estimate.	18%	18%	+3.2
Family, social services and the note to the judge. Estimate No public source provides a precise figure. This is our estimate.	16%	22%	+3.5
The bond, and the case not falling over. Estimate No public source provides a precise figure. This is our estimate.	16%	14%	+2.2
Total	100%		22%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low

IS WORK OVER?

23%

#311 / 633

Radiation oncologist

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
Contouring, fractions and the dose plan. Estimate No public source provides a precise figure. This is our estimate.	16%	48%	+7.7
Clinic, the tumour and what can be irradiated. Estimate No public source provides a precise figure. This is our estimate.	18%	18%	+3.2
Simulation, immobilisation and the machine day. Estimate No public source provides a precise figure. This is our estimate.	16%	22%	+3.5
Side effects, pauses and the patient who cannot take it. Estimate No public source provides a precise figure. This is our estimate.	16%	28%	+4.5
Board, the surgeon and the medical oncologist. Estimate No public source provides a precise figure. This is our estimate.	18%	14%	+2.5
Signing the plan and the dose that does not erase. Estimate No public source provides a precise figure. This is our estimate.	16%	12%	+1.9
Total	100%		23%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low